Development of a novel scoring system for predicting the risk of colorectal neoplasia: A retrospective study

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Ohno, Tomohiko ^a   Adachi, Seiji ^a   Okuno, Mitsuru ^a   Horibe, Yohei ^a   Goto, Naoe ^a   Iwama, Midori ^a   Yamauchi, Osamu ^a   Kojima, Takao ^a   Saito, Koshiro ^a   Ibuka, Takashi ^b   Yasuda, Ichiro ^b   Araki, Hiroshi ^b   Moriwaki, Hisataka ^b   Shimizu, Masahito ^b  

^a Gihoku Kosei Hospital   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; DRINKING BEHAVIOR; EARLY CANCER DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PREVALENCE; PROCEDURES; RECTUM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RECTUM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 85013790721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157269     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. Epub 2011/02/08. doi: 10.3322/caac.20107 PMID: 21296855.
2. Hiwatashi N, Morimoto T, Fukao A, Sato H, Sugahara N, Hisamichi S, et al. An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study. Jpn J Cancer Res. 1993; 84(11):1110-2. Epub 1993/11/01. PMID: 8276715.
3. Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer. 1995; 61(4):465-9. Epub 1995/05/16. PMID: 7759151.
4. Zappa M, Castiglione G, Grazzini G. Comments on: Should there be mass screening using faecal occult blood tests for colorectal cancer? Pro: Faivre, et al. Eur J Cancer 1998, 3(6), 773-780. Eur J Cancer. 1999; 3(2): 326. Epub 1999/08/17. PMID: 10448280.
5. Saito H, Soma Y, Nakajima M, Koeda J, Kawaguchi H, Kakizaki R, et al. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol Rep. 2000; 7(4):815-9. Epub 2000/06/16. PMID: 10854550.
6. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329 (27):1977-81. Epub 1993/12/30. doi: 10.1056/NEJM199312303292701 PMID: 8247072.
7. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369(12):1095-105. Epub 2013/09/21. doi: 10.1056/NEJMoa1301969 PMID: 24047059; PubMed Central PMCID: PMC3840160.
8. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012; 366(8):697-706. Epub 2012/ 02/24. doi: 10.1056/NEJMoa1108895 PMID: 22356323.
9. Colucci PM, Yale SH, Rall CJ. Colorectal polyps. Clin Med Res. 2003; 1(3):261-2. Epub 2005/06/03. PMID: 15931318; PubMed Central PMCID: PMC1069054.
10. Atkin WS, Valori R, Kuipers EJ, Hoff G, Senore C, Segnan N, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Colonoscopic surveillance following adenoma removal. Endoscopy. 2012; 44 Suppl 3:SE151-63. Epub 2012/10/04. doi: 10.1055/s-0032-1309821 PMID: 23012119.
11. Heitman SJ, Hilsden RJ, Au F, Dowden S, Manns BJ. Colorectal cancer screening for average-risk North Americans: an economic evaluation. PLoS Med. 2010; 7(11):e1000370. Epub 2010/12/03. doi: 10.1371/journal.pmed.1000370 PMID: 21124887; PubMed Central PMCID: PMC2990704.
12. Steffen A, MacInnis RJ, Joshy G, Giles GG, Banks E, Roder D. Development and validation of a risk score predicting risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2014; 23(11):2543-52. Epub 2014/08/05. doi: 10.1158/1055-9965.EPI-14-0206 PMID: 25087576.
13. Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013; 24(6):1207-22. Epub 2013/04/09. doi: 10.1007/s10552-013-0201-5 PMID: 23563998; PubMed Central PMCID: PMC4161278.
14. Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol. 2006; 101(8):1872-9. Epub 2006/06/23. doi: 10.1111/j.1572-0241.2006.00725.x PMID: 16790032.
15. van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut. 2011; 60(8):1094-102. Epub 2011/03/09. doi: 10.1136/gut.2010. 225011 PMID: 21383385.
16. Bongaerts BW, van den Brandt PA, Goldbohm RA, de Goeij AF, Weijenberg MP. Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites. Int J Cancer. 2008; 123 (10):2411-7. Epub 2008/08/30. doi: 10.1002/ijc.23774 PMID: 18752250.
17. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med. 1988; 319(9):533-7. Epub 1988/09/01. doi: 10.1056/NEJM198809013190902 PMID: 2841598.
18. Kedika R, Patel M, Pena Sahdala HN, Mahgoub A, Cipher D, Siddiqui AA. Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps. J Clin Gastroenterol. 2011; 45(2):e12-6. Epub 2010/08/11. doi: 10.1097/MCG. 0b013e3181ea1044 PMID: 20697294.
19. Makar GA, Holmes JH, Yang YX. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst. 2014; 106(2):djt374. Epub 2014/01/17. doi: 10.1093/jnci/djt374 PMID: 24431411; PubMed Central PMCID: PMC3952198.
20. Bu WJ, Song L, Zhao DY, Guo B, Liu J. Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies. Br J Clin Pharmacol. 2014; 78(2):301-9. Epub 2014/08/08. doi: 10.1111/bcp.12350 PMID: 25099257; PubMed Central PMCID: PMC4137822.
21. Cardel M, Jensen SM, Pottegard A, Jorgensen TL, Hallas J. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study. Cancer Med. 2014; 3(5):1458-66. Epub 2014/08/06. doi: 10.1002/cam4.306 PMID: 25091592
22. Hoffmeister M, Chang-Claude J, Brenner H. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Int J Cancer. 2007; 121(6):1325-30. Epub 2007/05/10. doi: 10.1002/ijc.22796 PMID: 17487832.
23. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010; 376(9754):1741-50. Epub 2010/10/26. doi: 10.1016/S0140-6736(10)61543-7 PMID: 20970847.
24. Smalley W, Ray WA, Daugherty J, Griffin MR. Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med. 1999; 159(2):161-6. Epub 1999/02/02. PMID: 9927099.
25. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006; 101(2):385-98. Epub 2006/02/04. doi: 10.1111/j.1572-0241.2006.00375.x PMID: 16454848.
26. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002; 12(1):1-9, v. Epub 2002/03/28. PMID: 11916153.
27. Tsugane S, Fahey MT, Sasaki S, Baba S. Alcohol consumption and all-cause and cancer mortality among middle-aged Japanese men: seven-year follow-up of the JPHC study Cohort I. Japan Public Health Center. Am J Epidemiol. 1999; 150(11):1201-7. Epub 1999/12/10. PMID: 10588080.
28. Zhu JZ, Wang YM, Zhou QY, Zhu KF, Yu CH, Li YM. Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma. Aliment Pharmacol Ther. 2014; 40(4):325-37. Epub 2014/06/20. doi: 10.1111/apt.12841 PMID: 24943329.
29. Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY, Wu DC, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011; 60(9):1236-41. Epub 2011/03/16. doi: 10.1136/gut.2010.221168 PMID: 21402615.
30. Colditz GA, Atwood KA, Emmons K, Monson RR, Willett WC, Trichopoulos D, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control. 2000; 11(6):477-88. Epub 2000/07/06. PMID: 10880030.
31. Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014; 63(7):1112-9. Epub 2014/01/05. doi: 10.1136/gutjnl-2013-304965 PMID: 24385598; PubMed Central PMCID: PMC4078748.
32. Aldridge AJ, Simson JN. Histological assessment of colorectal adenomas by size. Are polyps less than 10 mm in size clinically important? Eur J Surg. 2001; 167(10):777-81. Epub 2002/01/05. doi: 10.1080/ 11024150152707770 PMID: 11775731.
33. Ahlawat SK, Gupta N, Benjamin SB, Al-Kawas FH. Large colorectal polyps: endoscopic management and rate of malignancy: does size matter? J Clin Gastroenterol. 2011; 45(4):347-54. Epub 2010/09/28. doi: 10.1097/MCG.0b013e3181f3a2e0 PMID: 20871408.
34. Sakamoto T, Matsuda T, Nakajima T, Saito Y. Clinicopathological features of colorectal polyps: evaluation of the 'predict, resect and discard' strategies. Colorectal Dis. 2013; 15(6):e295-300. Epub 2013/03/ 27. doi: 10.1111/codi.12210 PMID: 23527478.
35. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011; 60(3):397-411. Epub 2010/ 11/03. doi: 10.1136/gut.2010.217182 PMID: 21036793; PubMed Central PMCID: PMC3040598.
36. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, et al. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013; 26(4):465-84. Epub 2013/01/12. doi: 10.1038/modpathol.2012.214 PMID: 23307060; PubMed Central PMCID: PMC3637979.
37. Colussi D, Brandi G, Bazzoli F, Ricciardiello L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci. 2013; 14(8):16365-85. Epub 2013/08/24. doi: 10.3390/ijms140816365 PMID: 23965959; PubMed Central PMCID: PMC3759916.
38. Kocarnik JM, Shiovitz S, Phipps AI. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep (Oxf). 2015; 3(4):269-76. Epub 2015/09/05. doi: 10.1093/gastro/ gov046 PMID: 26337942; PubMed Central PMCID: PMC4650976.
39. Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel). 2013; 5(2):676-713. Epub 2013/11/13. doi: 10.3390/cancers5020676 PMID: 24216997; PubMed Central PMCID: PMC3730326.
40. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010; 102(14):1012-22. Epub 2010/07/01. doi: 10.1093/jnci/djq201 PMID: 20587792; PubMed Central PMCID: PMC2915616.
41. Nishihara R, VanderWeele TJ, Shibuya K, Mittleman MA, Wang M, Field AE, et al. Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol. 2015; 30(10):1129-35. Epub 2015/10/09. doi: 10.1007/s10654-015-0088-4 PMID: 26445996; PubMed Central PMCID: PMC4639412.
42. Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010; 102(6):391-400. Epub 2010/03/09. doi: 10.1093/jnci/djq011 PMID: 20208017; PubMed Central PMCID: PMC2841037.
43. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin. 2007; 57(2):90-104. Epub 2007/03/30. PMID: 17392386.